Table 1.
Trials supporting the use of immunosuppressive drugs in the treatment of NMO.
| Drug | Date | Lead Author | Location | Population size |
|---|---|---|---|---|
| Azathioprine | 1998 | Mandler | United States | 7 |
| 2008 | McKeon | United States | 10 | |
| 2010 | Bichuetti | Brazil | 25 | |
| 2010 | Sarhaian | Iran | 28 | |
| 2011 | Constanzi | United States | 99 | |
| Mycophenolate | 2009 | Jacob | United States | 24 |
| Rituximab | 2005 | Cree | United States | 8 |
| 2008 | McKeon | United States | 8 | |
| 2008 | Jacob | United States | 25 | |
| 2011 | Bedi | United States | 23 | |
| 2011 | Pellkofer | Germany | 10 | |
| 2011 | Kim | Korea | 30 | |
| Methotrexate | 2000 | Minagar | United States | 8 |
| Oral corticosteroids | 2007 | Watanabe | Japan | 11 |
| Mitoxantrone | 2006 | Weinstock- Guttman |
United States | 5 |
| 2011 | Kim | Korea | 20 |